Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, Vile Parle (W), Mumbai, India.
Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, Vile Parle (W), Mumbai, India.
Biomed Pharmacother. 2018 Jan;97:38-44. doi: 10.1016/j.biopha.2017.10.127. Epub 2017 Nov 6.
The research in stem cells gives a proper information about basic mechanisms of human development and differentiation. The use of stem cells in new medicinal therapies includes treatment of different conditions such as spinal cord injury, diabetes mellitus, Parkinsonism, and cardiac disorders. These cells exhibit two unique properties: self-renewal and differentiation. The major stem cells been used for approximately about 10-14 years for cellular therapy are mesenchymal stem cells. Mesenchymal stem cells can individualize into many lineage, i.e. into both mesenchymal and non-mesenchymal lineage, such as into osteoblasts, chondrocytes, myocytes, adipocytes, neurons, etc. This review focuses on the history, types of stem cells and their targets and mechanisms of mesenchymal stem cells. Mesenchymal stem cells are the significant futuristic carrier for treating diseases associated not only with regeneration but also immunomodulation.
干细胞研究为人类发育和分化的基本机制提供了准确的信息。干细胞在新的医学治疗中的应用包括治疗多种疾病,如脊髓损伤、糖尿病、帕金森病和心脏疾病。这些细胞具有两个独特的特性:自我更新和分化。大约 10-14 年来,间充质干细胞一直被用于细胞治疗。间充质干细胞可以个体化分化为许多谱系,即间充质和非间充质谱系,如成骨细胞、软骨细胞、肌细胞、脂肪细胞、神经元等。这篇综述重点介绍了间充质干细胞的历史、类型及其靶点和作用机制。间充质干细胞是治疗疾病的重要未来载体,不仅与再生有关,还与免疫调节有关。